CLASS II Drug recall · Reported 4 Dec 2024 · FDA Enforcement Report
Equate Maximum Strength Lidocaine Pain Relieving Patch recalled
Unexo Life Sciences Private is recalling Equate Maximum Strength Lidocaine Pain Relieving Patch Lidocaine 4% Topical Anesthetic, 6, distributed nationwide in the US. The recall was initiated on 24 Oct 2024 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0068-2025
- FDA event ID
- 95595
- Recalling firm
- Unexo Life Sciences Private, New Delhi
- Manufacturer
- WALMART, INC
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 24 Oct 2024
- FDA classified
- 22 Nov 2024
- Reported
- 4 Dec 2024
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Pain Medication
Timeline
| 24 Oct 2024 | Recall initiated by company | |
| 22 Nov 2024 | Classified by FDA | +29 days |
| 4 Dec 2024 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP Deviations
Product as listed by the FDA
EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical Anesthetic, 6 patches per box PATCHES, LIDOCAINE 4%, Distributed by: Walmart Inc., Bentonville, AR 72716 NDC 79903-106-06
Where it was distributed
Nationwide in the US
Stores named: Walmart
Questions about this recall
Why was it recalled?
cGMP Deviations
Which lots are affected?
UPC 6 81131 07127 7
Where was it sold?
Nationwide in the US
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
10 other products · FDA event 95595This product is part of a recall event; the main page for the event is Theracare Cold Hot Medicated Patch, Menthol 5%, 5 patches recalled.
More recalls from Unexo Life Sciences Private
All 11| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | HealthWise Period Patch Menstrual Pain Relief, Menthol recalledHealthwise Menstrual Pain Relief Patch | Unexo Life Sciences Private | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Absorbine JR Pain Relieving Knee Patch, Camphor 7%, Menthol recalled | Unexo Life Sciences Private | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Cheeky Bonsai Pain Relief Patches, Menthol 10%, 4 patches recalled | Unexo Life Sciences Private | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Absorbine jr Ultra Strength Pain Patch, Menthol 6.5%, 1 patch recalled | Unexo Life Sciences Private | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | JR Watkins Cooling Pain Relief Patches, Menthol 7.5%, 5 patches recalled | Unexo Life Sciences Private | Manufacturing (CGMP) Deviations | Nationwide |
Other Lidocaine recalls
All 119| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg recalledXylocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS III | Lidolog Kit, Kit Contains: Lidocaine HCl Injection recalledLidolog Kit | Asclemed USA | Other | TN |
| Drug | CLASS II | Lidocaine HCl Injection, USP, 2%, 100 mg recalled by Fresenius Kabi USALidocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg recalledXylocaine | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Lidocaine HCl Injection USP, 1% (10 mg/mL) single dose ampule recalledLidocaine Hydrochloride | Asclemed USA | Sterility | Nationwide |